Adapsyn Bioscience leverages advanced chemical bioinformatics to discover and develop novel small molecules for therapeutic applications, as well as for use in agriculture, food, and nutrition. Their genomics platform is designed to identify microbial strains that produce unique chemical compounds, allowing for predictions regarding the chemotype, structure, and potential biological targets of these compounds. Additionally, their metabolomics platform facilitates the identification and isolation of both novel and known compounds produced by microbes, streamlining the evaluation process without the need for traditional cloning or cell-free production methods. This integrated approach enables the generation of diverse chemical libraries that can be subjected to extensive phenotypic characterization and high-content screening.

The applications of Adapsyn's technology span multiple sectors, including drug discovery, agriculture, and food and nutrition. In drug discovery, the company focuses on identifying and characterizing drug-like small molecules, advancing promising candidates for various therapeutic indications, including antineoplastic and anti-infective agents. In agriculture, their platform aids in pinpointing beneficial microbial compounds that can be evaluated for specific applications, while in the food and nutrition sector, it helps uncover novel ingredients and mechanisms behind the health benefits of probiotics and other microbial therapeutics. Overall, Adapsyn's innovative methodologies position them at the forefront of natural product discovery and development.

Canada

We apply proprietary computational tools to bacterial metabolomic and genomic data in order to identify, isolate, and assay novel drug-like small molecules in high-throughput to expedite the search for medicines that will better protect us from a wide spectrum of diseases.

Adapsyn Bioscience

Company Details